{"custom_id":"syn7239560","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn7239560\n\n##Evotec Drug-Target discovery\n\nThis site serves as the landing page for the upload and analysis of the drug target research carried out by [Evotec](https://www.evotec.com/). \n\n###Compound structures\nThe structure data for each of the drugs annotated by Evotec can be found in two tables. These include the [supplier-provided structures](https://www.synapse.org/#!Synapse:syn7239560/wiki/410637) and the [unique structure properties](https://www.synapse.org/#!Synapse:syn7239560/wiki/410636) computed from KNIME.\n\n###Compound Annotations\nThis resource contains numerous annotations of compounds. \n\n\n## Tables for Curation\n1. ID: syn65467787\nName: Compound Annotations from Evotec Drug Target Research\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: doc, sdf, csv, txt\n- Funders: CTF\n- Contains data created by: Tim James, Robert Allaway\n- Example files present: explanation.docx, unique_structures_with_calculated_properties.sdf, supplier_structures.sdf, pubchem_inactivity_unique_pairs.csv, chembl_matches.csv\n\n\n"}]}}{"custom_id":"syn4939906","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939906\n\n##Screening (Single Agent MIPEs, combo)\n\n**Initiative:** Cell Culture\n&nbsp;\n**Name:** Marc Ferrer, Ph.D. (NCATS)\n**Contact Email:** marc.ferrer@nih.gov\n**Dates:** 2014-2017 (ongoing)\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Efficacy, potency, and synergy data profiles, as well as pathways and targets\n&nbsp;\n**Background:** A lack of cellular model systems was identified as a major gap in pNF therapeutics-focused research when NTAP was launched in 2012. Hence, creating a cell culture initiative was an early priority. While current animal models can faithfully mimic some aspects of pNF (tumor histology, imaging characteristics, natural history), they are based on relatively narrow genetically engineered platforms and are not fully representative of human NF1 diversity. Moreover, the tumors in these models are slow growing (requiring 9-12 months for a single compound efficacy study) and costly. Hence, there is a need for in vivo models that allow more rapid drug screening (particularly when considering possible combinatorial therapies) and a need for in vitro models that allow more facile manipulation of the NF1 gene in order to understand the molecular genomics influencing tumor behavior. \n&nbsp;\n**Goals of Project:** \nTo create a panel of cell culture systems that represent pNF complexity and can be utilized to both screen new compounds as well as to identify new therapeutic targets.\n&nbsp;\n**Specific Aims:**\n1. Single agent screen of the MIPE 4.0 library of approx. 1912 small molecules against 9 different cell-lines (5 NF1 nullizygous, 1 carrier, 2 normal, and 1 control) with diverse modes of action, and the generation of single agent viability results for each cell line to ID ~40 top hits (with highest potency and efficacy)\n2. Execution of 6 x 6 screen of the top 40 compounds from initial screening, to elicit 780 combinations, such that the top 72 unique combinations (with preliminary optimal synergism profiles) can be elucidated\n3. Execution of 10 x 10 screen of top 72 compounds from 2nd screen, in order to focus on 9 combinations prioritized for validation in mouse NF1-/- primary Schwann cells.\n&nbsp;\n**Impact:** The screening studies yielded new data about drugs to be considered for pNF, new tools and guidelines for reproducible, transferable cell culture methodology for pNF and new biologic observations that may lead to unanticipated therapeutic discoveries.\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n**Curation Notes:**\nIn April 2021, Peggy Wallace, et al., determined that the ipnNF95.11c cell line, distributed by ATCC, is probably a / cell line, not a +/- cell line as was originally thought. Thus, the nf1Genotype annotation on data files for these samples has been altered from +/- to -/-,+/-.\n\n## Tables for Curation\n1. ID: syn51917001\nName: 10x10 Combination Screens of pNF Cell Lines\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens\n- Individual count: 4\n- Specimen count: 4\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Plexiform Neurofibroma, \n- Data types: drugCombinationScreen\n- File formats present: csv\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: iPNF05.5_10x10_CCG_16h_calc.csv, iPNF05.5_10x10_CCG_16h_metadata.csv, iPNF05.5_10x10_CCG_16h_responses.csv, iPNF05.5_10x10_CTG_48h_calc.csv, iPNF05.5_10x10_CTG_48h_metadata.csv\n\n\n\n2. ID: syn51917244\nName: 6x6 Combination Screens of pNF Cell Lines\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens\n- Individual count: 6\n- Specimen count: 6\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Plexiform Neurofibroma, \n- Data types: drugCombinationScreen\n- File formats present: csv\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: iPN02.3l_6x6_CTG_48h_calc.csv, iPN02.3l_6x6_CTG_48h_metadata.csv, iPN02.3l_6x6_CTG_48h_responses.csv, ipNF05.5_6x6_CTG_48h_calc.csv, ipNF05.5_6x6_CTG_48h_metadata.csv\n\n\n\n3. ID: syn51914953\nName: Single Agent Screens of pNF Cell Lines\nSummary:\n- Assays: cell viability assay, \n- Species: Homo sapiens, , Mus musculus\n- Individual count: 11\n- Specimen count: 11\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: , Plexiform Neurofibroma\n- Data types: drugScreen, \n- File formats present: csv, txt, png\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: NTAP ipNF02.3 2l MIPE qHTS.csv, NTAP ipNF02.8 MIPE qHTS.csv, NTAP ipNF05.5 MC MIPE qHTS.csv, NTAP ipNF05.5 SC MIPE qHTS.csv, NTAP ipNF06.2A MIPE qHTS.csv\n\n\n"}]}}{"custom_id":"syn53185180","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn53185180\n\n# Translating Basic Research towards Improved Clinical and Therapeutic Approaches\n## GFF - Other\n### Principal Investigator: Raymond Mattingly\n### Project Lead / Data Coordinator: Raymond Mattingly\n### Institution: Wayne State University\n### Project Description:\nSynergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers\nSummary: Activated RAS proteins drive the proliferation and survival of many human tumors. For example, in type 1 neurofibromatosis (NF1), loss of expression of neurofibromin allows hyper-activation of RAS. Drug treatments to block activated RAS have been long sought as a rational and targeted approach to treating cancer, but numerous obstacles have been discovered. We have designed a combinatorial approach to block the maturation of RAS in cellular models of malignant peripheral nerve sheath tumors (MPNSTs) from NF1 patients. The combination of a prodrug farnesyl transferase inhibitor (FTI) that is competitive with the prenyl co-factor of the enzyme plus a low dose of lovastatin to reduce cellular pools of prenyl precursors was effective and selective in blocking the proliferation of NF1 MPNST cells in vitro and in an orthotopic xenograft on the murine sciatic nerve. This approach could also be applicable to other cancers that are driven by activated RAS.\n\n\n## Tables for Curation\n1. ID: syn53185351\nName: Colony forming assays\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: S462TY colony formation.xlsx, Schwann_rat colony formation.xlsx, ST88-14 colony formation.xlsx\n\n\n"}]}}{"custom_id":"syn20608511","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn20608511\n\n#  Whole Body MRI of NF Patients\n\n### **Principal Investigator / Data Contributors:**  Dr. Wenli Cai ( @wcai ) and Dr. Gordon Harris\n### **Institution:** Massachusetts General Hospital (MGH)\n\n### General scientific questions:\n\nCan we identify features of MRIs to diagnose specific tumor types or predict disease progression? Can we improve upon current segmentation algorithms?  \n\nDataset: 2 image modalities (STIR and T1) from 48 NF1, NF2, and schwannomatosis patients using whole-body magnetic resonance imaging (WB MRI). We'll also provide matching structured clinical data (diagnosis, tumor burden, etc) to facilitate phenotypic analysis of the imaging data.\n\n### Data available: \n\n- Imaging: 96 stacks (two imaging modalities) from 48 patients with NF1, NF2 or Schwannomatosis. Image stacks are [here](https://www.synapse.org/#!Synapse:syn20704059). Combined .avis for each stack are also available in the [reports folder](https://www.synapse.org/#!Synapse:syn20708336).\n- Clinical metadata: tumor burden information including tumor type and location, available in clinical reports [here](https://www.synapse.org/#!Synapse:syn20708336).\n\n### Accessing the data:\n\nPlease navigate to [\"Accessing the Data\"](https://www.synapse.org/#!Synapse:syn20608511/wiki/595382) and follow the instructions to request access to the data. \n\n### Quality Assurance of the Data:\nWe will publish these 50 retrospectively collected WBMRI dataset for volumetric image analysis of whole-body MRI for patients diagnosed with NF, including NF1, NF2, and schwannomatosis. All these patients were scanned at MGH by using the clinical standard operational procedures for a clinical MRI system.  The image quality was examined by the board-certified radiologists. These are real clinical MRI data for longitudinal tracking of NF patients. \n\n## Tables for Curation\n1. ID: syn64962007\nName: Whole Body MRI of NF Patients\nSummary:\n- Assays: conventional MRI, \n- Species: Homo sapiens, \n- Individual count: 48\n- Specimen count: 48\n- Diagnoses present: Neurofibromatosis type 1, Schwannomatosis, Neurofibromatosis type 2, \n- Tumor types present: unknown, \n- Data types: image, \n- File formats present: DICOM, \n- Funders: CTF\n- Contains data created by: Robert Allaway, Jineta Banerjee\n- Example files present: 001-67.0.dcm, 016-83.0.dcm, 005-72.0.dcm, 008-75.0.dcm, 017-84.0.dcm\n\n\n"}]}}{"custom_id":"syn51133914","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn51133914\n\n${buttonlink?text=DHART SPORE Home Page&url=https://www%2Esynapse%2Eorg/#!Synapse:syn5666132/wiki/&highlight=true&align=None}\n\n# DHART SPORE Project 1 Phase 1 - Molecular, Developmental, and Genetic Evaluation of Plexiform Neurofibromas to Inform Clinical Trials\n## NIH-NCI - Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence\n### Principal Investigator: D. Wade Clapp, Jaishri Blakeley, Brigitte Widemann, Lu Le\n### Project Lead / Data Coordinator: D. Wade Clapp, Jaishri Blakeley, Brigitte Widemann, Lu Le\n### Institution: Indiana University; Johns Hopkins University; National Institutes of Health; University of Texas Southwestern Medical Center\n### Project Description:\nPlexiform neurofibromas (PNs) PNs are complex nerve and soft tissue tumors that affect 25-50% of people with NF1, cause serious lifelong morbidity and mortality due to organ compression, and progress to malignant peripheral nerve sheath tumors (MPNST) in ~8-13% of patients. Collaborative studies performed by Drs. Clapp and Luis Parada in a genetically engineered mouse (GEM) model of PNs unexpectedly demonstrated a central role of infiltrating Nf1 haploinsufficient bone marrow-derived mast cells in promoting the growth of PN lesions in vivo. These novel data led to a clinical trial administering imatinib mesylate to target aberrant stem cell factor (SCF)/c-kit signaling in the tumor microenvironment, which induced objective clinical responses in a subset of patients. Based on the observation that young children with head, neck, and airway tumors were most likely to have partial tumor regression, Drs. Robertson, Blakeley, Widemann and Michael Fisher are pursuing a registration trial in this patient population. More recently, studies in GEM models informed successful clinical trials of MEK inhibitors to directly inhibit aberrant Ras/Raf/MEK/ERK signaling in PN cells. The objective of Project 1 is to extend these promising data to investigate the developmental, molecular, and pharmacokinetic effects of c-kit and MEK inhibition alone and in combination. Our investigative team will characterize the adaptive responses of PNs to these kinase inhibitors in GEM models and in parallel studies in patients.\n\n## Tables for Curation\n1. ID: syn65468212\nName: Histopathology - Human PN , ANNUBP and MPNST Specimens\nSummary:\n- Assays: brightfield microscopy, \n- Species: Homo sapiens, \n- Individual count: 61\n- Specimen count: 61\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: [\"Plexiform Neurofibroma\"], [\"Fibromatosis\"], [\"Neurofibroma\"], [\"Malignant Peripheral Nerve Sheath Tumor\"], [\"Hemorrhagic Neoplasm\", \"Necrotic Neoplasm\"], , [\"ANNUBP\"]\n- Data types: image, \n- File formats present: svs, xml, pdf, xlsx, \n- Funders: NIH-NCI\n- Contains data created by: Steven Rhodes, Andrew Horvai, Elliot Stieglitz\n- Example files present: S12-24613 A1 PNF.svs, S12-24613 D8.svs, S15-14936 A5.svs, S15-14936 A5.xml, S15-33141 F3.svs\n\n\n\n2. ID: syn65468144\nName: Van Andel - Kinome\nSummary:\n- Assays: MIB/MS\n- Species: Homo sapiens\n- Individual count: 16\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: kinomics\n- File formats present: excel, csv\n- Funders: NIH-NCI\n- Contains data created by: Steven Angus, Sara Gosline\n- Example files present: CHOP-Le-VanAndel-Kinome-log2LFQ.xlsx, VA09_sampls_spore_kinome.csv, VA08_sampls_spore_kinome.csv, VA07_sampls_spore_kinome.csv, VA06_sampls_spore_kinome.csv\n\n\n"}]}}{"custom_id":"syn22268639","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22268639\n\n## **Understanding the role of purinerigic signaling on tumor formation in a mouse model of Neurofibromatosis Type 1**\n\n### CTF Young Investigator:\n#### Jennifer Patritti Cram\n\n### Investigator Institution:\nCincinnati Medical Center\n\n### Abstract:\nNeurofibromatosis type 1 (NF1) is a disorder that affects 1:3,000 individuals worldwide. Loss of function of the neurofibroma gene (NF1) causes over activation of the RAS oncogenic signaling pathway. People with NF1 have an increased risk of developing tumors (neurofibromas), both benign and malignant anywhere along the peripheral nervous system (PNS). Neurofibromas arise from Schwann cells (SCs) and/or Schwann cell precursors (SCP). SCs support axons in the peripheral nervous system (PNS). To date, there is no cure for this disease. Therefore, the purpose of this proposal is to identify potential treatments for NF1 by studying the mechanisms involved in tumor formation. \n\nTo identify potential markers and therapeutic targets for NF1, we performed microarray analysis on human plexiform neurofibromas. We dissociated human neurofibromas and sorted tumor derived cells into SCs (p75+/EGFR-) and SCP tumor-initiating cells (p75+/EGFR+) (p75 marks neural crest cells, SC precursors, and non-myelinating SCs, and EGFR+ marks cells that express the Epidermal Growth Factor Receptor) [Schwann cells are EGFR negative]. The hypothesis behind the cell sorting is that genes expressed in neurofibroma SCP-tumor initiating cells (p75+/EGFR+) more than in differentiated neurofibroma Schwann cells (p75+/EGFR-) contribute to tumor initiation. From this microarray study, we found that a purinergic receptor, P2RY14 expression was increased in SCP-like tumor initiating cells (p75+/EGFR+). Then, we sorted the SCP tumor initiating cells (p75+/EGFR+) into P2RY14 positive or negative (p75+/EGFR+/P2RY14+ or p75+/EGFR+/P2RY14-) and we found that the p75+/EGFR+/P2RY14+ cells show an increased ability to self-renew and form spheres in vitro. These results suggest that tumor initiating cells (p75+/EGFR+) that are P2RY14+ might drive tumor growth.\n\nTo test if P2RY14 is tumor promoting in vivo, I bred our genetically engineered neurofibroma mouse model (Nf1 fl/fl DhhCre) to P2RY14 knockout mice (P2RY14-/-). Knocking out P2RY14 in the neurofibroma mice (P2Y14-/-; Nf1 fl/fl DhhCre) increases survival and reduces tumor number. This data demonstrates that P2RY14 is involved in neurofibroma formation and that knockout of this receptor in the neurofibroma mouse model increases survival rate in neurofibroma bearing mice. \n\nI hypothesize that P2RY14 promotes neurofibroma growth by enhancing tumor cell self-renewal and/or proliferation in vitro and that inhibition of this receptor in vivo will result in a decrease of tumor growth. This hypothesis will be tested by completion of these specific aims:\n\n**Aim 1:** Determine if the P2RY14 receptor is necessary for neurofibroma tumor cell proliferation in vitro. I hypothesize that P2RY14 signaling promotes neurofibroma growth in a cell autonomous way by regulating SCP proliferation and/or self-renewal in vitro. A) To determine if P2RY14 activation affects SCP cell proliferation, I will measure proliferating cell rates in WT and Nf1-/- SCP after addition of UDP (P2RY14 agonist). B) To determine if P2RY14 is necessary for neurofibroma SCP proliferation, I will silence P2RY14 expression in WT and Nf1-/- SCP in vitro using the P2RY14 pharmacological inhibitor and/or short-hairpin RNA (shRNA) and measure the rate of proliferating cells. If a change is found, I will determine if the change is MAPK dependent by monitoring RAS signaling or, determine if the change is P2RY14 dependent by monitoring cAMP levels.\n\n**Aim 2:** Determine if the P2RY14 inhibitor drug can decrease neurofibroma growth. I will perform a drug study to determine if administration of a P2RY14 inhibitor by itself and/or in combination with the MEK inhibitor selumetinib for 7 days decreases cell proliferation, cell death, PKA and/or MAPK signaling. I will read out results by immunohistochemistry in tumor sections. If no change is found then, I will conclude that P2RY14 effects are mainly through tumor initiation. If an effect is seen, I will determine what cell types are involved in this process and increase the duration of the drug treatment to assess tumor size and tumor growth kinetics overtime.\n\nUpon completion of the proposed aims in this grant, I will determine if P2RY14 is necessary for neurofibroma tumor cell proliferation in vitro and test if P2RY14 inhibition by drug delivery has an effect on tumor growth in vivo.\n\nA critical gap in the field are the absence of mechanistic studies on the cause of tumor formation and the limited number of drugs available to treat NF1. Therefore, to fill this critical gap in knowledge, in Aim 1 I propose to determine if P2RY14 is necessary for neurofibroma cell proliferation in vitro. In Aim 2, I propose to determine if a P2RY14 pharmacological inhibitor can decrease neurofibroma growth.\n\nOur results will impact the neurofibroma field not only by defining purinergic signaling mechanisms relevant to neurofibroma development but I will also establish if the P2RY14 inhibitor can be used as a treatment for NF1.\n\n## Tables for Curation\n1. ID: syn64954874\nName: P2RY14 and NF1\nSummary:\n- Assays: western blot\n- Species: Homo sapiens, Mus musculus (humanized)\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Not Applicable, Neurofibroma\n- Data types: immunoassay\n- File formats present: pdf\n- Funders: CTF\n- Contains data created by: Jennifer Patritti Cram\n- Example files present: Figure 3F total ERK and pAKT-source data 3.pdf, Figure 3G-2-source data 1.pdf, Figure 4B-source data 1.pdf, Figure 4C neurofibroma b-actin-source data 1.pdf, Figure 4C neurofibroma P2RY14-source data 2.pdf\n\n\n"}]}}{"custom_id":"syn32128792","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn32128792\n\n# Genomic landscape of malignant peripheral nerve sheath tumor (MPNST) \n## NFRI - Genomics of MPNST (GeM) Consortium\n### Principal Investigator: David Miller\n### Project Lead / Data Coordinator: Katherine Piculell\n### Institution: Boston Children's Hospital\n### Project Description:\n####  Neurofibromatosis type 1 (NF1) is the most common tumor predisposition syndrome, and is associated with an aggressive soft-tissue sarcoma, malignant peripheral nerve sheath tumours (MPNSTs), the greatest cause of morbidity and mortality in people with NF1. The only potentially curative therapy involves surgery which is not always possible. Even therapy with curative intent is associated with poor overall survival for both sporadic and NF1-related MPNSTs. The development of novel therapies has been largely hindered by a lack of understanding of the molecular events underpinning MPNST pathogenesis. This is a comprehensive multi-omic study of MPNST evolution based on whole genome sequencing and transcriptomic data.  \n\n### PLEASE NOTE: This project links to data stored in EGA, annotated with the NF-OSI metadata dictionary to make this dataset visible in the NF Data Portal.  The data itself _is not available_ on Synapse or the NF Data Portal. You must request permission and access the data on [EGA](https://ega-archive.org/datasets/EGAD00001008608/).\n\n## Tables for Curation\n1. ID: syn38299187\nName: EGA Raw Data (requires approval on EGA)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 79\n- Specimen count: 139\n- Diagnoses present: Not Applicable, Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Not Applicable\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NFRI\n- Contains data created by: ?\n- Example files present: S00005M1_R1.fastq.gz, S00005M1_R2.fastq.gz, S00006M1_R1.fastq.gz, S00006M1_R2.fastq.gz, S00006M2_R1.fastq.gz\n\n\n\n2. ID: syn38893832\nName: EGAD00001008608 RNA-Seq Processed Data - quant.genes.sf (requires approval on EGA)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 79\n- Specimen count: 139\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Not Applicable\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: ?\n- Example files present: quant.genes.sf, quant.genes.sf, quant.genes.sf, quant.genes.sf, quant.genes.sf\n\n\n\n3. ID: syn58895011\nName: EGAD00001008608 RNA-Seq Processed Data - quant.sf (requires approval on EGA)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 79\n- Specimen count: 139\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Not Applicable\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: quant.sf, quant.sf, quant.sf, quant.sf, quant.sf\n\n\n"}]}}{"custom_id":"syn22268689","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22268689\n\n## **Identification and functional characterization of the substrates of LZTR1 (schwannomatosis)**\n\n### CTF Young Investigator:\n#### Aram Ko\n\n### Investigator Institution:\nColumbia University\n\n### Abstract:\nLZTR1 is a substrate adaptor protein of the CUL3 ubiquitin ligase complex whose substrates and cellular functions remain mostly unknown. Our laboratory reported for the first time that human brain tumors harbor somatic mutations of the LZTR1 gene. Later studies revealed that LZTR1 is somatically mutated across many types of human tumors. Furthermore, mutations of LZTR1 were identified as the causal event leading to a significant number of cases of schwannomatosis. Schwannomatosis is a rare form of Neurofibromatosis that has only recently been identified. The genetic disorder affects less than 1 in 40,000 people, and causes the development of schwannomas on cranial, spinal and peripheral nerves. Schwannomas may cause pain that may be hard to manage. Although the causal tumor suppressor role of LZTR1 as genetic basis of schwannomatosis has been firmly established, the mechanism by which loss of the activity of the LZTR1 ubiquitin ligases triggers tumor development remains elusive. Temporally coordinated destruction of key cell regulatory proteins by the Ubiquitin-Proteasome System (UPS) represents an important control mechanism to ensure that specific protein functions are turned off at the right time, in the right compartment, and in a unidirectional fashion. Cullin/Ring/Ligase complexes (CRL) control the proteolysis of many important cell regulators. In humans, there are approximately 200 CRL ligases, each characterized by a different substrate recognition subunit that provides specificity by directly recruiting the substrates. Cullin-3 is the molecular scaffold of a major class of CRLs that use BTB domain proteins as substrate-specific adaptors. Despite their large number, only a handful of BTB domain proteins have well-established substrates and their biological functions are largely unknown. Recently, RAS and Rit1 have been proposed as potential substrates of LZTR1. In the context of this work, it was suggested that LZTR1 may inhibit MAPK pathway by repressing RAS activity, but the mechanism of RAS inhibition remains controversial. Furthermore, the full scope of LZTR1 substrates and cellular functions remain unknown. \n\nHere, we will elucidate the normal biochemical and biological functions of LZTR1 and substrates and the mechanisms by which LZTR1 suppresses tumor growth. This work will use state of the art proteomics to identify and demonstrate the significance of crucial LZTR1 substrates in the context of cancer cells driven by LZTR1 inactivation. We anticipate that the proteomic-based discovery of new LZTR1 substrates will provide a major advance in our understanding of the links between ubiquitin ligases, tumor suppression and of the pathogenesis of Schwannomatosis and the many sporadic tumors driven by loss-of-function genetic alterations (mutations and deletions) of LZTR1. We postulate that LZTR1 substrates\nimplement oncogenic functions that are normally restrained by LZTR1-mediated ubiquitin-dependent degradation. The expected overall impact of this innovative grant application is that it will fundamentally advance our mechanistic understanding of the LZTR1 ubiquitin ligase as genetic driver of schwannomatosis and sporadic tumors and lay the foundation for the optimization of new therapeutic strategies in syndromic and sporadic tumors associated with loss-of-function genetic alterations of LZTR1.\n\n### Acknowledgement:\nData was provided by:\n\n**Ko A, Hasanain M, Oh YT, D'Angelo F, Sommer D, Frangaj B, Tran S, Bielle F, Pollo B, Paterra R, Mokhtari K, Soni RK, Peyre M, Eoli M, Papi L, Kalamarides M, Sanson M, Iavarone A, Lasorella A. LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL. Cancer Discov. 2023 Mar 1;13(3):702-723. doi: 10.1158/2159-8290.CD-22-0376. PMID: 36445254.**\n\nThe results published here are in whole or in part based on data obtained from the NF Data Portal (http://www.nf.synapse.org, RRID:SCR_021683) and made available through the NF Open Science Initiative.\n**Accessing the data from this study requires a Synapse account.**\n\n## Tables for Curation\n1. ID: syn64954875\nName: Proteomics\nSummary:\n- Assays: mass spectrometry, TMT quantitation, \n- Species: Mus musculus, Homo sapiens, \n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: Not Applicable, \n- Tumor types present: Not Applicable, Glioblastoma, \n- Data types: proteomics, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Aram Ko, James Moon\n- Example files present: DiGly proteomics.xlsx, immunoprecipitation mass spectrometry.xlsx, TMT.xlsx, synapse_storage_manifest_proteomicsassaytemplate.csv\n\n\n\n2. ID: syn64954876\nName: in vitro viability assay\nSummary:\n- Assays: cell viability assay, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Not Applicable, \n- Data types: drugCombinationScreen, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Aram Ko, James Moon\n- Example files present: in vitro viability assay.xlsx, synapse_storage_manifest_clinicalassaytemplate.csv\n\n\n"}]}}{"custom_id":"syn11374345","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374345\n\n###Leveraging human induced pluripotent stem cells (iPSCs) to determine the impact of patient-derived NF1 gene mutations on peripheral sensory neuron-driven Schwann cell growth\n&nbsp;\n\n#####**PI:**  David H. Gutmann, MD, PhD\n#####**Team:** Corina Anastasaki, PhD, Jason B. Papke, MS, and Morgan E. Freret, MS\n\n**University of Washington**\n\n&nbsp;\n\n######**Background and Rationale:**  \n\nCutaneous or dermal neurofibromas (cNFs) represent one of the signature tumor types in individuals with the Neurofibromatosis type 1 (NF1) cancer predisposition syndrome. These benign tumors are composed of neoplastic Schwann cells embedded in a microenvironment containing terminal nerve endings, fibroblasts, mast cells, and macrophages. While caused by loss of NF1 protein function in Schwannian lineage cells, studies in mouse plexiform neurofibroma models have revealed a critical role for non-neoplastic stromal cells (fibroblasts, mast cells, and macrophages) in tumor formation, maintenance, and continued growth. In this regard, inhibition of stromal cell (mast cells, macrophages) function in preclinical genetically-engineered mice resulted in attenuated plexiform neurofibroma growth. In addition to fibroblasts, mast cells, and macrophages, the NF1-deficient Schwann cells in cNFs often grow in proximity to terminal nerve endings. The intimate relationship between neurons and Schwann cells during normal peripheral nervous system development and function raises the intriguing possibility that neurons are important drivers of cNF growth. This notion is supported by recent studies in which the proliferation of myelinating cells in the central nervous system (oligodendrocytes) is regulated by neuronal production of a novel growth factor (neuroligin-3). Based on these provocative findings, **we hypothesize that peripheral sensory neurons accelerate NF1-deficient Schwann cell growth through the elaboration of mitogens.** To identify these potentially clinically-actionable mitogens, we have designed a series of milestone-driven experiments using a novel collection of patient-derived and isogenic human induced pluripotent stem cells harboring NF1-patient germline NF1 gene mutations.\n\n&nbsp;\n\n######**Study Design:**\n\nThe overall conceptual framework for this proposal is illustrated in the **Figure**, where the differential impact of the germline NF1 gene mutation in sensory neurons on human NF1-deficient Schwann cell growth will be analyzed.\n\n&nbsp;\n\n${image?fileName=gutmann%2Epng&align=Center&scale=100&responsive=true}\n\n&nbsp;\n\n######**Deliverables and Timeline:**\n\n&nbsp;\n\n${image?fileName=gutmannTable%2Epng&align=Center&scale=100&responsive=true}\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn64954745\nName: 12 month deliverables\nSummary:\n- Assays: , immunofluorescence, real-time PCR\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: , image, geneExpression, metadata\n- File formats present: pdf, png, excel, \n- Funders: NTAP\n- Contains data created by: Corina Anastasaki\n- Example files present: Progress report July 2019.pdf, Figure 1.png, Figure 2.png, Figure 3.png, Figure 4.png\n\n\n\n2. ID: syn64954746\nName: 18 month deliverables - Jan 2020\nSummary:\n- Assays: , immunocytochemistry, real-time PCR\n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: , image, geneExpression, metadata\n- File formats present: doc, pdf, excel, png, \n- Funders: NTAP\n- Contains data created by: Corina Anastasaki, Christina Parry\n- Example files present: Progress report Jan 2020.docx, Figure 1 BRN3A NF200 over time.pdf, Figure 2 Peripherin TRKA CALCA TRKB TRKC PV.pdf, qPCR relative expression data.xlsx, Group 1 WK3 NF200 BRN3A.png\n\n\n\n3. ID: syn64954747\nName: 30 month deliverables -  December 2020\nSummary:\n- Assays: local field potential recording, array, cell proliferation, cell count, western blot, immunocytochemistry, immunohistochemistry, \n- Species: Homo sapiens, Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: electrophysiology, image, raw counts, metadata\n- File formats present: , excel\n- Funders: NTAP\n- Contains data created by: Corina Anastasaki\n- Example files present: collated MEA sensory data.xlsx, Sensory burst frequency.emf, Sensory mean firing.emf, Sensory network burst frequency.emf, DRG NSCs proliferation data.xlsx\n\n\n\n4. ID: syn64954748\nName: 6 month deliverables\nSummary:\n- Assays: immunocytochemistry, , western blot, quantitative PCR\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: image, , metadata\n- File formats present: png, doc, tif, \n- Funders: NTAP\n- Contains data created by: Corina Anastasaki\n- Example files present: all schwann cell markers Figure 5.png, Combined progress report.docx, Figure 2 (2).tif, Figure 3 (2).tif, Figure 4 (2).tif\n\n\n"}]}}{"custom_id":"syn9727752","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn9727752\n\n${image?fileName=CTF Synodos Data Site Headers5%2Ejpg&align=Center&scale=100&responsive=true}\n###**Welcome to the Synodos Schwannomatosis Data Portal**\n\nSynodos for Schwannomatosis was a two-year initiative that will bring together basic, translational, and clinical researchers towards the end goal of developing effective treatments for schwannomatosis. The project aims to perform an extensive molecular analysis of schwannomatosis tumor samples to identify new therapeutic targets, and advance the understanding and management of the disease, with a focus on pain. Experts from institutions spread across four different countries are working together to:\n1. Develop a clinically annotated schwannomatosis biobank;\n2. Develop a comprehensive pain registry for schwannomatosis patients\n3. Establish the genomic and epigenomic landscape of schwannomatosis to identify disease-driving alterations; and,\n4. Correlate the molecular findings with key clinical parameters, including pain.\n\nThis site serves as the landing page for all data and analysis coming from this project. Further details can also be found on the [study details page](https://nf.synapse.org/Explore/Studies/DetailsPage?studyId=syn9727752) for this project on the [NF Data Portal](https://nf.synapse.org/).\n\nIf you are new to the project, please register for an account and learn how to start working with the data by reading the [Accessing the Data](https://www.synapse.org/#!Synapse:syn9727752/wiki/424913) page to the left. \n\n---\n${buttonlink?text=Visit Study Details Page&url=https://nf%2Esynapse%2Eorg/Explore/Studies/DetailsPage%3FstudyId%3Dsyn9727752&align=None}\n${buttonlink?text=Back to CTF Data Portal&url=https://nf%2Esynapse%2Eorg/Organizations/DetailsPage%3Fabbreviation%3DCTF&align=None}\n\n\n## Tables for Curation\n1. ID: syn53604698\nName: Deep Variant Tumor Calls\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: \n- Example files present: \n\n\n\n2. ID: syn64954726\nName: Methylation\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens\n- Individual count: 45\n- Specimen count: 91\n- Diagnoses present: Schwannomatosis\n- Tumor types present: Schwannoma\n- Data types: chromatinActivity\n- File formats present: idat\n- Funders: CTF\n- Contains data created by: Sheila Mansouri\n- Example files present: 202259490164_R07C01_Red.idat, 202259490164_R07C01_Grn.idat, 202262730105_R08C01_Red.idat, 202262730105_R08C01_Grn.idat, 202262730105_R07C01_Red.idat\n\n\n\n3. ID: syn64954727\nName: RNAseq\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, \n- Individual count: 14\n- Specimen count: 24\n- Diagnoses present: , Schwannomatosis\n- Tumor types present: Schwannoma, \n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: swn_patient_64_tumor_121_S7_L001_R1_001.fastq.gz, swn_patient_64_tumor_121_S7_L001_R2_001.fastq.gz, swn_patient_64_tumor_121_S7_L002_R1_001.fastq.gz, swn_patient_64_tumor_121_S7_L002_R2_001.fastq.gz, swn_patient_64_tumor_121_S7_L003_R1_001.fastq.gz\n\n\n\n4. ID: syn30423895\nName: SWNTS_processing_2020-05-13\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: ?\n- Example files present: ?\n\n\n\n5. ID: syn43709762\nName: Schwannomatosis RNA-seq Raw Data (NF-OSI Merged fastq)\nSummary:\n- Assays: rnaSeq\n- Species: Homo sapiens\n- Individual count: 14\n- Specimen count: 24\n- Diagnoses present: Schwannomatosis, \n- Tumor types present: Schwannoma\n- Data types: ?\n- File formats present: fastq\n- Funders: ?\n- Contains data created by: ?\n- Example files present: swn_patient_10_tumor_111_2.merged.fastq.gz, swn_patient_10_tumor_109_2.merged.fastq.gz, swn_patient_10_tumor_110_1.merged.fastq.gz, swn_patient_10_tumor_108_1.merged.fastq.gz, swn_patient_63_tumor_123_1.merged.fastq.gz\n\n\n\n6. ID: syn41825491\nName: Schwannomatosis RNA-seq Raw Data (Unmerged, Original fastq)\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: ?\n- Example files present: ?\n\n\n\n7. ID: syn63540453\nName: Schwannomatosis RNA-seq quant.sf files\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 14\n- Specimen count: 22\n- Diagnoses present: Schwannomatosis\n- Tumor types present: Schwannoma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: quant.sf, quant.genes.sf, quant.genes.sf, quant.sf, quant.sf\n\n\n\n8. ID: syn53403828\nName: Somatic Mutations\nSummary:\n- Assays: \n- Species: \n- Individual count: 0\n- Specimen count: 0\n- Diagnoses present: \n- Tumor types present: ?\n- Data types: \n- File formats present: \n- Funders: CTF\n- Contains data created by: ?\n- Example files present: Strelka_swn_patient_45_tumor_139_vs_swn_patient_45_blood_somatic_snvs.vcf.gz, Strelka_swn_patient_25_tumor_56_vs_swn_patient_25_blood_somatic_snvs.vcf.gz.tbi, Strelka_swn_patient_3_tumor_32_vs_swn_patient_3_blood_somatic_snvs.vcf.gz, Strelka_swn_patient_45_tumor_139_vs_swn_patient_45_blood_somatic_snvs.vcf.gz.tbi, Strelka_swn_patient_25_tumor_56_vs_swn_patient_25_blood_somatic_snvs.vcf.gz\n\n\n\n9. ID: syn64720237\nName: Somatic Variants - Strelka - WES\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 22\n- Specimen count: 40\n- Diagnoses present: Schwannomatosis\n- Tumor types present: Schwannoma\n- Data types: SomaticVariants\n- File formats present: vcf\n- Funders: CTF\n- Contains data created by: Sasha Scott\n- Example files present: swn_patient_10_tumor_108_vs_swn_patient_10_blood.strelka.somatic_snvs.vcf.gz, swn_patient_10_tumor_109_vs_swn_patient_10_blood.strelka.somatic_snvs.vcf.gz, swn_patient_10_tumor_108_vs_swn_patient_10_blood.strelka.somatic_indels.vcf.gz, swn_patient_10_tumor_109_vs_swn_patient_10_blood.strelka.somatic_indels.vcf.gz, swn_patient_10_tumor_110_vs_swn_patient_10_blood.strelka.somatic_snvs.vcf.gz\n\n\n\n10. ID: syn64954728\nName: Whole genome sequencing\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 18\n- Diagnoses present: Schwannomatosis, \n- Tumor types present: schwannoma, Not Applicable, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: swn_patient_3_tumor_32_S3_L006_R2_001.fastq.gz, swn_patient_17_blood_S5_L006_R1_001.fastq.gz, swn_patient_17_blood_S5_L006_R2_001.fastq.gz, swn_patient_25_blood_S6_L007_R1_001.fastq.gz, swn_patient_25_blood_S6_L007_R2_001.fastq.gz\n\n\n\n11. ID: syn64954729\nName: whole exome sequencing\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 38\n- Specimen count: 91\n- Diagnoses present: Schwannomatosis, \n- Tumor types present: Schwannoma, \n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: swn_patient_19_tumor_29_1.fastq.gz, swn_patient_41_blood_1.fastq.gz, swn_patient_8_tumor_30_2.fastq.gz, 009_swn_patient_1_blood_ACC8LEANXX_CATCAAGT-TCTTTCCC_L007.R2.fastq.gz, 025_swn_patient_51_tumor_2_BCD0UFANXX_GCTAACGA_L001.R2.fastq.gz\n\n\n"}]}}{"custom_id":"syn4939916","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939916\n\n##Transition to Confirmatory and Secondary Screening of Plexiform Neurofibroma Models in 96-well Format\n**Initiative:** Unsolicited\n&nbsp;\n**Name:** Raymond Mattingly, Ph.D.\n**Contact Email:** rmatting@med.wayne.edu\n**Dates:** 8-1-15 to 10-31-16\n**Tumor Focus:** plexiform neurofibroma\n**Application:** Translational models\n&nbsp;\n**Background:** \nIn our [primary NTAP project](syn7217928) we developed and optimized 3D models of NF1 plexiform neurofibromas (PNs) with the goal of providing efficient and effective systems for secondary screening of compounds that would be identified as promising new approaches for these tumors. Another primary NTAP project was performed at NCATS to screen for potential therapeutics using the CellTiter-Glo assay of proliferation as the read-out in a 1536-well 2D growth format.\n&nbsp;\n**Goals of Project:** \nTo prove that cells grown in 3D matrices, as compared to those growing in 2D (on plastic) will exhibit drug sensitivity that is a better clinical predictor. We will perform confirmatory and secondary assays in collaboration with NCATS. We will develop a 96-well format Cell-Titer Glo assay procedure for 2D and 3D PN cultures that will be useful for general confirmatory testing. We expect that the 2D results should directly reproduce those of the initial screen, i.e., that the outcome is independent of the platform (1536-well vs. 96-well) or performance site (NCATS vs. WSU). Further, with transition to the 3D culture, 96-well format assay, we will advance from confirmation to a secondary screen of initial results. We hypothesize that cells growing in 3D matrices, as compared to those growing in 2D on plastic, will exhibit drug sensitivity that is a better predictor of eventual clinical effectiveness.\n&nbsp;\n**Impact:** \n1. We have developed and optimized assays of proliferation of 3D PN cultures in 96-well plates to provide secondary screening of potential drug treatments. \n2. The fact that some potential treatments for NF1 PNs, as defined by their ability to inhibit growth in 2D cultures, are much less active against the 3D PN models could be highly significant. Inherent resistance to initially promising compounds is often encountered when transferring from in vitro screens to subsequent in vivo testing. If the 3D models can better predict which screening hits are likely to subsequently fail to be effective then they will be of great value.\n&nbsp;\n\n**Publications:** manuscript(s) in process\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn65467786\nName: Screening of Plexiform Neurofibroma Models in 96-well Format\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma\n- Data types: drugScreen\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Markiesha Baines\n- Example files present: Drug 01_4000cells_3D.xlsx, Drug 01_1500cells_2D.xlsx, Drug 01_8000cells_2D.xlsx, Drug 02_8000cells_2D.xlsx, Drug 02_1500cells_2D.xlsx\n\n\n"}]}}{"custom_id":"syn11374333","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374333\n\n###Cutaneous Neurofibroma: Models, Biology and Translation\n\n&nbsp;\n\n#####**PI:** Lu Q. Le, M.D., Ph.D. \n**University of Texas Southwestern Medical Center**\n\n&nbsp;\n\n######**Background and Rationale:**  \n\nNeurofibromatosis type 1 (NF1) is a genetic disorder that affects around 1:3000 live births. While the disease has nearly 100% penetrance in patients, NF1 has a diverse spectrum of manifestations. Hallmark traits of the disease include café-au-lait macules, cutaneous neurofibromas (cNF), plexiform neurofibromas (pNF) and malignant peripheral nerve sheath tumors (MPNST), among other symptoms. In NF1 patients, cNFs usually arise at puberty and beyond, can range widely in size and number, and can cause itching, pain, superficial infections as well as psychosocial and cosmetic burdens. Currently, there is no approved therapeutic option for cNFs aside from elective surgery. The development of new therapeutic approaches for cNF will require an understanding of the cNF cellular origin that can be used to elucidate mechanisms that underpin cNF formation and growth. While biallelic inactivation of NF1 in neoplastic Schwann cells is essential for cNF formation, it is not sufficient, pointing to the critical roles of other genetic or epigenetic changes as well as extrinsic signals from other cell types in the tumor microenvironment. While the field has made significant inroads towards our understanding of these tumors, there are still gaps in our knowledge of cNF pathogenesis that could be addressed by the adoption of a systemic approach to decipher all the biological steps in cNF development from the cell of origin to tumor stage to identify the “rate limiting step” that can be therapeutically targeted to prevent or delay cNF formation. Therefore, in this application, we propose a set specific aims to fill this knowledge gap: We will define the identity of the cNF cell of origin in mice that will guide us to identify the cells of origin for human cNF. We will next decipher how the cell of origin and the tumor microenvironment contribute to drive cNF initiation that will uncover its pathogenesis to delineate biological steps and mechanisms in tumor development as well as generating of preclinical models system that elucidate cNF biology and enable preclinical therapeutic testing.\n\n&nbsp;\n\n######**Goals, Innovation and Potential Impact:**\nOur overall project will advance via two parallel but interwoven efforts: \n\n1. Characterize cNF cell of origin to trace their developmental origin as well as to define their phenotypes and interactions with the tumor microenvironment. This will provide a framework for elucidating the functional contributions of cNF cell of origin in neurofibroma development. \n2. To determine biological steps that are critical for cNF development. A major innovation in our work is linking these approaches in a synergistic manner to our novel neurofibroma models that can be used broadly to decipher the pathogenesis as well as pre-clinical models for therapeutic testing.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\nResults for some of the work from this project have been published in Cancer Discovery (Chen et al, Cancer Discovery, 2019). [Click here](http://cancerdiscovery.aacrjournals.org/content/9/1/114.long)\n\n## Tables for Curation\n1. ID: syn64954730\nName: 12 month deliverables\nSummary:\n- Assays: immunofluorescence, \n- Species: ?\n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: , \n- Tumor types present: , \n- Data types: image, \n- File formats present: tif, \n- Funders: NTAP\n- Contains data created by: Lu Le, Robert Allaway\n- Example files present: Figure 1.tif, Figure 2.tif, Figure 3.tif, Figure 4.tif, Figure 5.tif\n\n\n\n2. ID: syn64954731\nName: 18 month deliverables\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunofluorescence\n- File formats present: tif\n- Funders: NTAP\n- Contains data created by: Lu Le\n- Example files present: Figure 1.tif, Figure 4.tif, Figure 5.tif, Figure 6.tif, Figure 7.tif\n\n\n\n3. ID: syn64954732\nName: 24 month deliverables\nSummary:\n- Assays: , immunofluorescence, brightfield microscopy, immunohistochemistry, quantitative PCR, immunocytochemistry, western blot\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , Teratoma, Plexiform Neurofibroma, Cutaneous Neurofibroma\n- Data types: , geneExpression, image\n- File formats present: , jpg\n- Funders: NTAP\n- Contains data created by: Lu Le\n- Example files present: Figure 2.tif, Figure 3.tif, Figure 4.tif, Figure 5.tif, Figure 1.tif\n\n\n\n4. ID: syn64954733\nName: 36 month deliverables\nSummary:\n- Assays: immunohistochemistry, reporter gene assay, brightfield microscopy, immunofluorescence, cell count, whole exome sequencing, \n- Species: Mus musculus, Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable, Neurofibromatosis type 1, \n- Tumor types present: , Cutaneous Neurofibroma, Not Applicable, Plexiform Neurofibroma\n- Data types: geneExpression, image, \n- File formats present: jpg, \n- Funders: NTAP\n- Contains data created by: Renee McKay\n- Example files present: pNF Nf null SKPs+nf het DRG GAP43.jpg, pNF Nf null SKPs+Nf het DRG LacZ hi mag.jpg, pNF Nf null SKPs+Nf het DRG LacZ.jpg, pNF Nf null SKPs+Nf het nerve GAP43.jpg, pNF Nf null SKPs+Nf het nerve hi mag.jpg\n\n\n\n5. ID: syn64954734\nName: 6 month deliverables\nSummary:\n- Assays: immunofluorescence, \n- Species: ?\n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: , \n- Data types: image, \n- File formats present: jpg, \n- Funders: NTAP\n- Contains data created by: Lu Le, Robert Allaway\n- Example files present: Figure 1.jpg, Figure 2.jpg, Figure 3.jpg, synapse_storage_manifest.csv\n\n\n"}]}}{"custom_id":"syn21650493","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn21650493\n\n\n##Retina regeneration in zebrafish-Endogenous RGC replacement\n\n##VRI Subgroup: \nEndogenous RGC Replacement\n\n##Principal Investigator: \nDaniel Goldman, PhD (University of Michigan)\n\n##Personnel:\nAresh Sahu, PhD (Post-Doc)\nJonathan Jui PhD (Post-Doc)\nSulochan Devi, PhD (Research Associate)\nMuchu Zhou, PhD (Research Technician)\n\n##Lay Abstract\n\nNF1 is a disease resulting from reduced levels of neurofibromin 1 that functions as a tumor suppressor. One in five children with NF1 have optic nerve tumors that can lead to retinal ganglion cell death and blindness. One approach for treating NF1-related blindness is to regenerate retinal ganglion cells from endogenous stem cells. Because zebrafish use endogenous stem cells to regenerate retinal ganglion cells, we propose that understanding this process in fish will inform us of strategies for stimulating a similar process in humans. With this goal in mind, we aim to identify gene expression changes and small molecules that are sufficient to drive retina regeneration in zebrafish and test their effect on retina regeneration in mammals.\n\n\n## Tables for Curation\n1. ID: syn64954827\nName: AAV Ascl1 v YapS5A EdU\nSummary:\n- Assays: immunofluorescence, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: raw counts, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Mouse AAV 20220219 EdU+cells.xlsx, synapse_storage_manifest.csv\n\n\n\n2. ID: syn64954828\nName: AAV Ascl1 v YapS5A EdU image\nSummary:\n- Assays: immunofluorescence, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: tif, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: mouse AAV ascl1 v yapS5A EdU.tif, synapse_storage_manifest.csv\n\n\n\n3. ID: syn64954829\nName: ATACseq Ascl1a lin28a OE v control uninj Muller glia\nSummary:\n- Assays: , ATAC-seq\n- Species: Danio rerio, \n- Individual count: 4\n- Specimen count: 5\n- Diagnoses present: , Not Applicable\n- Tumor types present: , Not Applicable\n- Data types: chromatinActivity, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  , Christina Parry\n- Example files present: 2971-SD-1_TAAGGCGA-GTGTAGAT_S107_R1_001.fastq.gz, 2971-SD-1_TAAGGCGA-GTGTAGAT_S107_R2_001.fastq.gz, 2971-SD-3_TCCTGAGC-GTGTAGAT_S109_R1_001.fastq.gz, 2971-SD-2_AGGCAGAA-GTGTAGAT_S108_R1_001.fastq.gz, 2971-SD-2_AGGCAGAA-GTGTAGAT_S108_R2_001.fastq.gz\n\n\n\n4. ID: syn64954830\nName: ATACseq DAPT v DMSO\nSummary:\n- Assays: ATAC-seq, \n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: NA, \n- Data types: raw counts, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: uninj_DAPT_MG_1_R1.fastq.gz, uninj_DAPT_MG_1_R2.fastq.gz, uninj_DAPT_MG_2_R1.fastq.gz, uninj_DAPT_MG_2_R2.fastq.gz, uninj_DAPT_MG_3_R1.fastq.gz\n\n\n\n5. ID: syn64954831\nName: ATACseq inj v uninj\nSummary:\n- Assays: ATAC-seq, \n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: NA, \n- Data types: raw counts, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: inj_4dpi_MG_1_R1.fastq.gz, inj_4dpi_MG_1_R2.fastq.gz, inj_4dpi_MG_2_R1.fastq.gz, inj_4dpi_MG_2_R2.fastq.gz, inj_4dpi_MG_3_R1.fastq.gz\n\n\n\n6. ID: syn64954832\nName: Cxcl18b injury dep gene exp\nSummary:\n- Assays: quantitative PCR, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: cxcl18b qPCR.xlsx, synapse_storage_manifest.csv\n\n\n\n7. ID: syn64954833\nName: Cxcl18b knockdown EdU\nSummary:\n- Assays: ?\n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: cxcl18b EdU.xlsx, synapse_storage_manifest.csv\n\n\n\n8. ID: syn64954834\nName: Drug screen\nSummary:\n- Assays: ?\n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: drugScreen, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: drug screeing data.xlsx, synapse_storage_manifest.csv\n\n\n\n9. ID: syn64954835\nName: Flt1 knockdown and mutant EdU injury data\nSummary:\n- Assays: immunofluorescence, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Flt1 knockdow and mutant EdU injury data.xlsx, synapse_storage_manifest.csv\n\n\n\n10. ID: syn64954836\nName: Images NF1 knockdown\nSummary:\n- Assays: immunofluorescence, \n- Species: nan, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: NA, \n- Data types: image, \n- File formats present: tif, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: control MO-330_c1+2.tif, control MO-333_c1+2.tif, control MO-342_c1+2.tif, NF1 MO-451_c1+2.tif, NF1 MO-463_c1+2.tif\n\n\n\n11. ID: syn64954837\nName: Myc\nSummary:\n- Assays: quantitative PCR, immunofluorescence, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, cellularPhysiology, \n- File formats present: excel, tif, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: myc family gene exp.xlsx, Mych, mycb knockdown and mutant EdU TUNEL.xlsx, Fig 2 myc.tif, Fig 3 myc.tif, Fig 1 myc.tif\n\n\n\n12. ID: syn64954838\nName: NF1 qPCR and MO knockdown\nSummary:\n- Assays: quantitative PCR, \n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: NA, \n- Data types: geneExpression, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: morpholino nf1, ascl1a.xlsx, nf1 qPCR data 4 expt.xlsx, synapse_storage_manifest.csv\n\n\n\n13. ID: syn64954840\nName: RNAseq Ascl1a-Lin28a v control\nSummary:\n- Assays: RNA-seq, \n- Species: Danio rerio, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: nan, \n- Tumor types present: nan, \n- Data types: geneExpression, \n- File formats present: bam, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Sample_1091-JJ-8.genome.bam, Sample_1091-JJ-9.genome.bam, Sample_1091-JJ-10.genome.bam, Sample_128293.genome.bam, Sample_128294.genome.bam\n\n\n\n14. ID: syn64954841\nName: RNAseq DAPT v DMSO MG\nSummary:\n- Assays: RNA-seq, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: 121565_AGTTCAGG-CCAACAGA_S1_L003_R1_001.fastq.gz, 121566_GACCTGAA-TTGGTGAG_S2_L003_R1_001.fastq.gz, 121567_TCTCTACT-CGCGGTTC_S3_L003_R1_001.fastq.gz, 121568_CTCTCGTC-TATAACCT_S4_L003_R1_001.fastq.gz, 121569_CCAAGTCT-AAGGATGA_S5_L003_R1_001.fastq.gz\n\n\n\n15. ID: syn64954842\nName: RNAseq inj v uninj MG\nSummary:\n- Assays: RNA-seq, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: 14131_GTGAAA_L003_R1_001.fastq.gz, 14131_GTGAAA_L003_R1_002.fastq.gz, 14131_GTGAAA_L003_R1_003.fastq.gz, 14131_GTGAAA_L003_R1_004.fastq.gz, 14131_GTGAAA_L003_R1_005.fastq.gz\n\n\n\n16. ID: syn64954843\nName: RNAseq uninj v inj retina non-Muller glia\nSummary:\n- Assays: RNA-seq, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Sample_134894_R1.fastq.gz, Sample_134894_R2.fastq.gz, Sample_134896_R1.fastq.gz, Sample_134896_R2.fastq.gz, Sample_134897_R1.fastq.gz\n\n\n\n17. ID: syn64954845\nName: Vegf signaling component gene expression\nSummary:\n- Assays: quantitative PCR, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: Vegf signaling component gene expression qPCR.xlsx, synapse_storage_manifest.csv\n\n\n\n18. ID: syn64954846\nName: scRNAseq zf retina\nSummary:\n- Assays: single-cell RNA-seq, \n- Species: Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: GFF\n- Contains data created by:  \n- Example files present: MG_GFP_1_S9_L000_R1_001.fastq.gz, MG_GFP_1_S9_L000_R2_001.fastq.gz, MG_GFP_1_S10_L000_R1_001.fastq.gz, MG_GFP_1_S10_L000_R2_001.fastq.gz, MG_GFP_1_S11_L000_R1_001.fastq.gz\n\n\n"}]}}{"custom_id":"syn27761862","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn27761862\n\n# Leveraging Synodos NF2 data to test novel single and combination drugs in NF2-deficient meningioma models\n## CTF - Drug Discovery Initiative Registered Reports\n### Principal Investigator: Vijaya Ramesh (PI), Lei Xu (Co-investigator)\n### Project Lead / Data Coordinator: Roberta Beauchamp\n### Institution: Massachusetts General Hospital\n### Project Description:\nMeningiomas arise from meningothelial arachnoid cap cells and are the most common primary intracranial tumors in adults. NF2 inactivation is frequently associated with primary atypical (WHO grade II) tumors. Meningiomas that progress despite surgery and radiation are responsible for significant morbidity and mortality. Therefore, effective systemic therapies are greatly needed. For meningioma modeling and preclinical drug screening, we employ human primary meningioma (MN) cell lines derived from surgically resected tumors and CRISPR-Cas9 genome-edited isogenic, human arachnoidal cell lines (ACs) that either express or lack NF2. Employing these models, we established that NF2-deficient meningiomas reveal aberrant activation of mTORC1/mTORC2 signaling, which led to clinical trials for NF2 and meningiomas. In Synodos for NF2 project, we undertook large-scale kinome, transcriptome and drug screening studies in our AC and MN cell models to identify other potential targets. Kinome and transcriptome data revealed increased activation and expression of several EPH receptor family tyrosine kinases (EPH-RTKs), Src family kinase members (SFKs) and c-KIT. Our large-scale drug screening efforts, in collaboration with NIH-NCATS, revealed a set of proteasome inhibitors exhibiting cytotoxic effects with selectivity toward NF2-null cells. Taken together, here we propose to examine three different drugs targeting the proteasome (provided by Millennium/Takeda Pharmaceutical, and two NUAK2 specific inhibitors alone and combined with TAK-228 (mTOR inhibitor) in 2 grade I and 2 grade II MN lines as well as human Schwann cells (SC) with NF2 loss. Anti-tumor efficacy of proteasome drugs will also be evaluated in orthotopic NF2-deficient SC and MN models. Our overall approach of leveraging the ‘omics and drug screening results from Synodos for NF2 studies for further testing in our in vitro and orthotopic NF2-deficient in vivo meningioma models is timely, novel and will provide a framework to pursue new avenues in NF2 research and for clinical care.\n\n## Tables for Curation\n1. ID: syn65467792\nName: Proteasome-targeting drugs tested on NF2-deficient meningioma models\nSummary:\n- Assays: cell viability assay, \n- Species: Homo sapiens, Mus musculus, \n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: , \n- Tumor types present: , Meningioma, \n- Data types: drugScreen, \n- File formats present: ?\n- Funders: CTF\n- Contains data created by: Roberta Beauchamp, Anh Nguyet Vu\n- Example files present: NF2+_AC-CRISPR drug treatment.xlsx, NF2-_AC-CRISPR-A17 drug treatment.xlsx, NF2-_AC-CRISPR-A19 drug treatment.xlsx, NF2-_Ben-Men-1 drug treatment.xlsx, NF2-_MN597 drug treatment.xlsx\n\n\n"}]}}{"custom_id":"syn11374341","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374341\n\n###Microenvironmental targets of cutaneous neurofibromas: T-cells and mast cells as tumor contributors\n&nbsp;\n\n#####**PIs:**  Juha and Sirkku Peltonen\n**Institution**: University of Turku \n**E-mail**: uhpel@utu.fi and sipelto@utu.fi\n&nbsp;\n\n######**Background and Rationale:**  \n\nImmunity has a central and complex role in tumor growth, which can be utilized when developing new treatment modalities for tumors. To date, the role of immune system in cNFs has gained little attention. Transformed cells are normally eradicated by cooperation of innate and adaptive immune cells. Immune surveillance could be expected to recognize neurofibromin neoepitopes resulting from the second hit of the NF1 gene, but this is not taking place in cNFs. Mast cells are known to be abundant in cNFs and they are increasingly more interesting as druggable targets in tumor biology and neurogenic itch. It is also not known whether mast cells of cNFs are tumorigenic or anti- tumorigenic.\n\n&nbsp;\n\n######**Expected Outcomes:**\nTo prove that T cells and mast cells are valid targets for the treatment of cNF. Elucidating the characteristics, roles and effects of these prominent tumor microenvironment components in promoting tumorigenesis could be used to facilitate finding of targeted therapies for the treatment of cNF. The therapeutic modalities include those already approved and those being developed for tumor biology as well as for inflammatory diseases.\n\n&nbsp;\n\n######**Challenges/Gaps:**\nThere are challenges in the sensitivity of mass spectrometry with single cell samples. T cell receptor sequencing is advancing fast but to date the algorithms still need to be developed to predict T cell specificity form T cell receptor sequence.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954741\nName: Kallionpaa et al., Dermatology 2022\nSummary:\n- Assays: brightfield microscopy\n- Species: Homo sapiens, Human\n- Individual count: 61\n- Specimen count: 183\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: image, \n- File formats present: jpg, excel\n- Funders: NTAP\n- Contains data created by: Roope Kallionpää\n- Example files present: CD117_01.jpg, CD117_02.jpg, CD117_03.jpg, CD117_04.jpg, CD117_05.jpg\n\n\n\n2. ID: syn64954742\nName: Kallionpaa et al., Immune cell populations in cNFs, T cell receptor sequencing\nSummary:\n- Assays: ?\n- Species: Human\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: cutaneous neurofibroma\n- Data types: ?\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Roope Kallionpää\n- Example files present: TCR_sequencing_Kallionpaa_et_al.xlsx\n\n\n\n3. ID: syn64954744\nName: Kallionpaa et al., Mass spectrometry of human cutaneous neurofibromas and the overlying skin\nSummary:\n- Assays: LC-MSMS\n- Species: Human\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: proteomics\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Roope Kallionpää\n- Example files present: MS_dataset_Kallionpaa_et_al.xlsx\n\n\n"}]}}{"custom_id":"syn11374337","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374337\n\n###Use of the mouse model of cutaneous NFs for identification of cells of origin and drug screening studies\n&nbsp;\n\n#####**PI:** Piotr Topilko\n\n&nbsp;\n\n######**Background and Rationale:**  \n\n\nDespite major progress in the understanding of the mechanisms driving development of NFs, the cells of origin and scenario governing initiation of cNFs, remains unknown. We have recently shown that the neural crest derived boundary cap (BC) cells, transiently present at the interface between central and peripheral nervous system in a mouse embryo, migrate sequentially along nerve roots and along peripheral nerves under the skin, two locations where NFs develop with a higher incidence in NF1 patients. Furthermore, in the adult skin, BC derivatives correspond to various types of Schwann cells and dermal stem cells with gliogenic potential, two cell populations considered as the primary pathogenic target of NF1. Based on these observations, we hypothesized that BCs could be directly implicated in the development NFs. To explore such possibility, we have generated mouse line carrying NF1 loss combined with fluorescent tracer in BC cells and their derivatives. All mutant mice develop both paraspinal plexiform and cutaneous NFs whose location and cellular composition faithfully recapitulates NFs present in human NF1 patients.\n\n&nbsp;\n\n######**Goal:**\n\nThe aim of this study is to take advantage of this unique model and our extensive expertise of NF1 pathology and of mechanisms governing the development of Schwann cells to tackle three important issues concerning the _initiation and progression_, _cellular origin_ and _novel treatment_ of cNFs.\n\n&nbsp;\n\n######**Collaboration:**\n\nThe success of this project implies close collaboration with two other Partners: the team of Dr. Anne-Marie Schmitt from Pierre Fabre Research Institute and of Professor Pierre Wolkenstein from Hopital Henri Mondor, both from France. Together, we propose well-integrated and complementary aims requiring the specific skills and knowledge of all Partners that are indispensable for the technical and conceptual aspects of this study.\n\nResults from some of this work have been published in Cancer Discovery (Radomska, et al. Cancer Discovery, 2019).  [Click here](http://cancerdiscovery.aacrjournals.org/content/9/1/130.long)\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954735\nName: Chronic injuries experiment\nSummary:\n- Assays: immunofluorescence, \n- Species: Mus musculus, \n- Individual count: 27\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Not Applicable, , Cutaneous Neurofibroma\n- Data types: image, \n- File formats present: tif, , czi\n- Funders: NTAP\n- Contains data created by: Piotr Topilko\n- Example files present: CF287.zip, CF583.zip, CF584.zip, CF588.zip, CF819.zip\n\n\n\n2. ID: syn64954736\nName: Development of cNFs\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Piotr Topilko\n- Example files present: 2021-04-28 PP.zip, 2021-05-18 PP.zip, 2021-05-27 PP.zip, 2021-06-09 PP.zip, 2021-06-11 PP.zip\n\n\n\n3. ID: syn64954737\nName: Grafts of tumor cells into sciatic nerve\nSummary:\n- Assays: in vivo tumor growth, \n- Species: Mus musculus, \n- Individual count: 11\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: image, \n- File formats present: jpg, \n- Funders: NTAP\n- Contains data created by: Piotr Topilko, Christina Parry\n- Example files present: D_2021-05-18-sphere_Hetero_c Image005.jpg, E_2021-05-18-sphere_Hetero_c-Image002 .jpg, F_2021-05-18-sphere_Hetero_c-Image003 .jpg, G_2021-05-18-sphere_Hetero_D- 153 .jpg, H_2021-05-18-sphere_Hetero_D.-221 .jpg\n\n\n\n4. ID: syn63944429\nName: Mouse model cutaneous imaging of chronic injuries\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: 27\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Piotr Topilko\n- Example files present: CF287.zip, CF583.zip, CF584.zip, CF588.zip, CF819.zip\n\n\n\n5. ID: syn51199726\nName: NFOSI-RNASeq-To-Process-2023-15-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Piotr Topilko\n- Example files present: reads_P75-P0-1.fastq.bz2, reads_P75-P0-2.fastq.bz2, reads_P75-P0-3.fastq.bz2, reads_P75-P5-1.fastq.bz2, reads_P75-P5-2.fastq.bz2\n\n\n\n6. ID: syn64954738\nName: RNAseq Bulk Sphere P0 vs P5\nSummary:\n- Assays: RNA-seq, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Not Applicable, \n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: NTAP\n- Contains data created by: Piotr Topilko, Kaitlin Throgmorton\n- Example files present: reads_P75-P0-1.fastq.bz2, reads_P75-P0-2.fastq.bz2, reads_P75-P0-3.fastq.bz2, reads_P75-P5-1.fastq.bz2, reads_P75-P5-2.fastq.bz2\n\n\n\n7. ID: syn64954739\nName: Single cell transcriptomic analysis, for the identification of new markers of supepidermal glia\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: fastq, \n- Funders: NTAP\n- Contains data created by: Piotr Topilko\n- Example files present: Sample_2019_M_fastq_path.zip, Sample_2020_10_fastq_path.zip, 2019-014_S1_L001_I1_001.fastq.gz, 2019-014_S1_L001_R1_001.fastq.gz, 2019-014_S1_L001_R2_001.fastq.gz\n\n\n\n8. ID: syn64954740\nName: Vascular detection with Itae\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: jpg\n- Funders: NTAP\n- Contains data created by: Piotr Topilko\n- Example files present: 1.1-0.jpg, 1.1-1.jpg, 1.1.jpg, a1.1-0.jpg, a1.2-0.jpg\n\n\n"}]}}{"custom_id":"syn11638893","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11638893\n\n###Development of a Preclinical NF1-MPNST Platform Suitable for Precision Oncology Drug Discovery and Evaluation\n&nbsp;\n#####**PI:**  Angela C. Hirbe, MD, PhD\n\n**Washington University School of Medicine in St. Louis**\n\n&nbsp;\n\n######**Technical Background and Rationale:** \n\nOne of the most common malignancies affecting adults with neurofibromatosis type 1 (NF1) are malignant peripheral nerve sheath tumors (MPNSTs), highly aggressive sarcomas that typically develop from benign plexiform neurofibromas. 8-13% of individuals with NF1 will develop MPNSTs during young adulthood.  There are few therapeutic options, and the vast majority of people with these cancers will die within 5 years of diagnosis. Despite advances in our understanding of the pathobiology of these tumors and the identification of seemingly-promising therapeutic targets using a single mouse MPNST model system (NPCis mice and derivative cell lines), no investigational agents have demonstrated efficacy following translation to human clinical trials. However, there is limited genetic diversity being modeled in these systems, which does not capture the full spectrum of genetic diversity that characterizes human NF1-MPNSTs. In this regard, p53 loss, a common feature of the currently-used preclinical models, is observed in a minority of human MPNSTs. We hypothesize that one of the major reasons that rationally-chosen drugs underperform in human clinical trials is that the preclinical models used to discover and evaluate promising therapeutic agents do not capture the genetic heterogeneity of the human cancer. To optimize clinical translation, we aim to develop a collection of MPNST Patient Derived Xenografts (MPNST-PDXs) for the NF community, which more fully represent the spectrum of genetic heterogeneity seen in the human condition.  \n\n&nbsp;\n\n######**Hypothesis and Specific Aims:**\n\nMalignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas, which occur at an increased frequency in individuals with NF1, where they often arise from a benign plexiform neurofibroma. Currently, the only curative therapy involves complete surgical resection; however, this is often impossible due to the size or the degree of invasiveness of the primary tumor or the presence of metastatic disease at diagnosis.  In this situation, therapy is often limited to standard cytotoxic chemotherapy or enrollment in a clinical trial using rationally-chosen molecularly-targeted therapies.  Despite advances in our understanding of the biology of MPNSTs, no successful clinical trials have resulted in improved survival for individuals with NF1-MPNST. For example, while EGFR inhibition was effective in shrinking murine Nf1/p53 MPNSTs,1 no activity was demonstrated in a phase II clinical trial.2 Similarly, subsequent trials also based on preclinical model successes failed to show efficacy when translated to human clinical trials (sorafenib or imatinib). **We hypothesize that the poor translation of preclinical findings to the bedside reflect three barriers: **\n\n1. current preclinical models do not encompass the spectrum of genetic heterogeneity observed in human MPNSTs \n2. Treatments may work better for one disease subtype, which is currently not captured using a single genetic model, and \n3. NF1-MPNSTs may develop adaptive mechanisms that allow for escape from the effects of therapy. \n\n&nbsp;\n\nIn this proposal, we plan to **address those _three barriers_ **by: \n1. generating human preclinical models that more fully recapitulate the genetic diversity seen in human NF1-MPNSTs, \n2. evaluating the responsiveness to conventional and targeted therapies using a diverse collection of patient-derived MPNST xenograft models, and \n3. defining potential therapeutic escape mechanisms. The generation of these NF1-MPNST lines will serve as a valuable resource for the NF research community relevant to the design and evaluation of future therapeutic strategies to treat NF1-MPNST.\n\n&nbsp;\n\n######**Objectives:**\nThe main goal of this research project is to develop a set of NF1-MPNST PDX lines that captures the spectrum of molecular heterogeneity of the human disease. The proposal aims to meet the following objectives:\n\na. Create enabling resources including 10 NF1-MPNST PDX lines for preclinical studies.\nb. Histologically and genomically characterize these 10 NF1-MPNST PDX lines, thereby defining the molecular heterogeneity of these tumors.\nc. Determine whether there is a correlation between molecular subtype and response to chemotherapy or targeted therapy.\nd. Assess potential adaptive mechanisms or tumor resistance by assessing genomic changes following treatment.\n\n&nbsp;\n\n######**Milestones and Deliverables:**\n\n**Period 1 objectives a and b:**\nDefine MPNST molecular heterogeneity by developing and characterizing NF1-MPNST Patient-Derived Xenograft (PDX) lines.\n• Histologic characterization of 4 lines\n• Begin development of two more lines\n• Send RNA and DNA for sequencing on 5 lines (the line used as preliminary data in the grant and the 4 others characterized above)\n\n&nbsp;\n\n**Period 2 objectives a and b:**\nDefine MPNST molecular heterogeneity by developing and characterizing NF1-MPNST Patient-Derived Xenograft (PDX) lines.\n• Histologic characterization of 2 lines\n• Begin development of one more line\n• Send RNA and DNA for sequencing on 3 lines\n\n&nbsp;\n\n**Period 3 objectives a and b:**\nDefine MPNST molecular heterogeneity by developing and characterizing NF1-MPNST Patient-Derived Xenograft (PDX) lines.\n• Generation of 2 PDX lines\n• Histologic characterization of 2 PDX lines\n• Send RNA and DNA for sequencing on 2 lines\n\n&nbsp;\n\n**Period 4 objective c:**\nDetermine whether there is a correlation between the specific mutational subtype and the response of the tumors to conventional therapy.\n• In vivo murine experiments with anthracyclines\n\n&nbsp;\n\n**Period 5 objective c:**\nDetermine whether there is a correlation between the specific mutational subtype and the response of the tumors to targeted therapy.\n• In vivo murine experiments with mTOR inhibitors and potentially other drugs\n\n&nbsp;\n\n**Period 6 objective d:**\nAssess potential adaptive mechanisms of tumor resistance by examining changes in gene expression following treatment.\n• In vivo murine experiments with sequencing and other tumor analyses post treatment with chemotherapy and targeted agents\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn52298742\nName: Copy Number Variation - CNVkit\nSummary:\n- Assays: ?\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 10\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: NF Service\n- Example files present: JHU002-048.converted.antitargetcoverage.cnn, JHU002-048.converted.call.cns, JHU002-048.converted-diagram.pdf, JHU002-048.converted-scatter.png, JHU023-049.converted-scatter.png\n\n\n\n2. ID: syn42174758\nName: Filtered Single Cell RNASeq Data\nSummary:\n- Assays: single-cell RNA-seq\n- Species: Homo sapiens\n- Individual count: 8\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: geneExpression\n- File formats present: tsv, mtx\n- Funders: NTAP,NFRI\n- Contains data created by: ?\n- Example files present: barcodes.tsv.gz, features.tsv.gz, matrix.mtx.gz, barcodes.tsv.gz, features.tsv.gz\n\n\n\n3. ID: syn35563963\nName: Germline Genomic Variants - DeepVariant Pipeline (from syn31715607)\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 9\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: \n- File formats present: vcf\n- Funders: NTAP,NFRI\n- Contains data created by: NF Service\n- Example files present: JHU031-045.vcf.gz, JHU002-048.vcf.gz, JHU031-050.vcf.gz, WU505-041.vcf.gz, JHU023-044.vcf.gz\n\n\n\n4. ID: syn35563960\nName: Germline Genomic Variants - FreeBayes Pipeline (from syn31715607)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 9\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP,NFRI\n- Contains data created by: NF Service\n- Example files present: FreeBayes_JHU023-044.vcf.gz.tbi, FreeBayes_JHU023-049.vcf.gz.tbi, FreeBayes_JHU031-045.vcf.gz.tbi, FreeBayes_JHU002-048.vcf.gz, FreeBayes_WU505-041.vcf.gz.tbi\n\n\n\n5. ID: syn35563961\nName: Germline Genomic Variants - Mutect2 Pipeline (from syn31715607)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 9\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP,NFRI\n- Contains data created by: NF Service\n- Example files present: Mutect2_unfiltered_JHU002-048.vcf.gz.tbi, Mutect2_unfiltered_JHU002-048.vcf.gz, Mutect2_unfiltered_JHU023-044.vcf.gz.tbi, Mutect2_filtered_JHU023-044.vcf.gz.tbi, Mutect2_unfiltered_JHU031-045.vcf.gz\n\n\n\n6. ID: syn35563962\nName: Germline Genomic Variants - Strelka Pipeline (from syn31715607)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 9\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP,NFRI\n- Contains data created by: NF Service\n- Example files present: Strelka_JHU002-048_variants.vcf.gz.tbi, Strelka_JHU002-048_genome.vcf.gz.tbi, Strelka_JHU023-049_genome.vcf.gz.tbi, Strelka_JHU002-048_variants.vcf.gz, Strelka_JHU023-044_variants.vcf.gz.tbi\n\n\n\n7. ID: syn63093965\nName: NFOSI-WES-To-Process-2024-09\nSummary:\n- Assays: whole exome sequencing, \n- Species: Mus musculus (humanized), Homo sapiens, \n- Individual count: 6\n- Specimen count: 13\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: NTAP,NFRI\n- Contains data created by: Chang In Moon\n- Example files present: ATGGCGAA-CGATAGAG_S8_L003_R1_001.fastq.gz, ATAAGGCG-TCTAACGC_S9_L002_R2_001.fastq.gz, GTACTCTC-TACCAGGA_S17_L003_R2_001.fastq.gz, TCCAATCG-GTCAGTTG_S23_L003_R1_001.fastq.gz, TGTTGTGG-AAGGACAC_S28_L003_R1_001.fastq.gz\n\n\n\n8. ID: syn29783617\nName: NFOSIprocessing-2022-26-04\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens, Mus musculus (humanized)\n- Individual count: 5\n- Specimen count: 11\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: genomicVariants\n- File formats present: bam\n- Funders: NTAP,NFRI\n- Contains data created by: Chang In Moon\n- Example files present: step2_mkdup_hg38_TWFE-JHU002-43_2-lib1_tumor.bam, step2_mkdup_hg38_TWFE-JHU002-48-lib1_normal.bam, step2_mkdup_hg38_TWFE-JHU023-44-lib1_tumor.bam, step2_mkdup_hg38_TWFE-JHU023-49-lib1_normal.bam, step2_mkdup_hg38_TWFE-JHU031-45-lib1_tumor.bam\n\n\n"}]}}{"custom_id":"syn23662493","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn23662493\n\n\n# Developing an Improved mAb Against Neurofibromin\n\n### **Principal Investigator:** Michelle Mattson-Hoss, PhD\n### **Company:** Infixion Bioscience, Inc.\n\n### Project Description: \nNeurofibromatosis Type 1 (NF1) is an autosomal dominant genetic disorder in which the amount of wild type neurofibromin produced by the remaining functional gene is a significant factor in the progression and severity of NF1 symptoms (i.e., haploinsufficiency driven). Given neurofibromin’s impact in regulating the Ras pathway and the importance of neurofibromin protein levels directly impacting many downstream pathways the availability of sensitive and specific antibodies to facilitate protein measurement becomes critically important.\n\nUnfortunately, commercially available NF1 antibodies (both polyclonal and monoclonal) have been shown to have significant limitations, including the inability to use these antibodies in ELISA and IHC applications. Utilizing full-length neurofibromin (isolated and purified by the Frank McCormick lab and Dominic Esposito’s team at the Frederick National Lab) as the immunogen, and leveraging a proprietary antibody development platform, Alicanto©, from Digital Proteomics, LLC, the San Diego-based team at Infixion Bioscience set out to develop a new and improved monoclonal antibody against NF1. Project goals include:\n1) identifying a mAb with increased sensitivity and specificity against neurofibromin as determined by western blot, and \n2) demonstrate expanded utility with function in ELISAs, sandwich ELISAs and immunohistochemistry (IHC) applications.\n\nAdditional collaborating partners on the project included: Dr. Michael Frost (IHC development), Dr. Dominic Esposito (epitope mapping), and Dr. Eduard Serra Lab (characterization in NF1 iPSC lines).\n\n\n## Tables for Curation\n1. ID: syn64954907\nName: Affinity Purified ELISA Screen\nSummary:\n- Assays: ELISA\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay\n- File formats present: csv\n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: AP_NF1-His_ELISA.csv\n\n\n\n2. ID: syn64954908\nName: Epitope Mapping\nSummary:\n- Assays: western blot, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: tif, \n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: 211027 NF1 07E Merge.tif, 211027 NF1 07E AntiMBP.tif, 201105 07E.tif, 211027 NF1 07E Anti NF1.tif, synapse_storage_manifest.csv\n\n\n\n3. ID: syn64954909\nName: IHC Data\nSummary:\n- Assays: immunohistochemistry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: nan, \n- Tumor types present: ?\n- Data types: image, \n- File formats present: tif, pdf, excel, \n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: iNF1-07E IHC - 1-20 of Adrenal.tif, iNF1-07E IHC - 1-20 of Cerbellar cortex 1.tif, iNF1-07E IHC - 1-20 of Cerbellar cortex 2.tif, iNF1-07E IHC - 1-20 of Cerbral cortex - occipital lobe.tif, iNF1-07E IHC - 1-20 of Cerbral cortex.tif\n\n\n\n4. ID: syn64954910\nName: Sandwich ELISA\nSummary:\n- Assays: ?\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: ?\n- Data types: immunoassay, \n- File formats present: txt, \n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: 20210204_Sandwich ELISA.txt, synapse_storage_manifest.csv\n\n\n\n5. ID: syn64954911\nName: Sequence Data\nSummary:\n- Assays: liquid chromatography/tandem mass spectrometry, next generation targeted sequencing\n- Species: Oryctolagus cuniculus\n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: proteomics, geneExpression\n- File formats present: mzML, tsv\n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: MSB48021HCPeps052620.mzML.gz, MSB48021HCTryp052620.mzML.gz, MSB48021LCChym052520.mzML.gz, MSB48021LCElas052520.mzML.gz, MSB48021LCPeps052520.mzML.gz\n\n\n\n6. ID: syn64954912\nName: Titer Report\nSummary:\n- Assays: ELISA\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: PAC 14429, 14430-final.pdf\n\n\n\n7. ID: syn64954913\nName: Western Blot Screening\nSummary:\n- Assays: western blot\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: [\"Not Applicable\", \"Plexiform Neurofibroma\"]\n- Data types: image\n- File formats present: png\n- Funders: NTAP\n- Contains data created by: Michelle Mattson-Hoss\n- Example files present: 05D.png, 06G.png, 07E.png, 08D.png, 10D.png\n\n\n"}]}}{"custom_id":"syn4939888","params":{"model":"claude-3-7-sonnet-20250219","max_tokens":6000,"system":"You are Syndi, a highly competent and helpful data assistant.","messages":[{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939888\n\n##Development of Patient Reported Outcomes System for Patients with NF1-Associated Plexiform Neurofibromas using Mixed Method Approach\n**Initiative:** PRO\n&nbsp;\n**Name:** Jin-Shei Lai, Ph.D.\n**Contact Email:** js-lai@northwestern.edu \n**Dates:** 2-1-14 to 5-31-18\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Clinical Endpoint Tool\n&nbsp;\n**Background:** \nPatient Reported Outcome (PRO) measures assess the treatment outcomes most relevant to patients, and constitute potential outcomes to evaluate in clinical trials. PROs meeting FDA guidelines are critical to ensuring patient-centered endpoints are incorporated. Historically, NF1-associated plexiform neurofibromas (pNF) treatment trials have under-utilized PROs specific to pNF. A psychometrically sound measure incorporating input from patients, families and clinicians, is critical for inclusion in treatment trials. To address the need for a pNF-specific PRO measure for use in clinical trials, this project sought to develop a PRO measurement system utilizing input from patients, families and clinicians, as well as well as psychometric analysis methods to ensure the developed measures are reliable and valid.\n&nbsp;\n**Goals of Project:** \nAdvancing a PRO system for children and young adults with pNF by (1) establishing a conceptual model describing HRQOL, 2) Developing item pools (e.g.,  pain, stigma, and organ dysfucntion measures), 3) Evaluating psychometric properties of the pools, 4) affirming clinical differences.\n&nbsp;\n**Specific Aims:** \n1a. To establish a conceptual model describing health-related quality of life (HRQOL) for patients with pNF across the lifespan via individual interviews with patients, parents, and clinicians. This ensures inclusion of the patient’s voice in future clinical trials. \n1b. To develop item pools based on findings from Aim 1a and literature review. We anticipated that pain, stigma and organ dysfunction measures would be developed, with the possibility of additional domains, some from existing instruments. \n2. To develop a PRO system for patients with pNF across the lifespan by evaluating the psychometric properties of the existing, modified, and newly developed item pools from Aim 1. \n3. To establish clinically important differences (IDs) for the PRO system developed in Aim 2. This will enable evaluation of clinical interventions’ impact upon patient-reported symptoms using clinically-based and psychometrically-sound methodology consistent with FDA guidance for PROs. \n\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn65467781\nName: Patient Reported Outcomes Dataset\nSummary:\n- Assays: questionnaire\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: surveyData\n- File formats present: dat, pdf, csv\n- Funders: NTAP\n- Contains data created by: Jin-Shei Lai, Sara Gosline\n- Example files present: ntappeds_finalforanalysis.sas7bdat, NTAP Pediatric PRO Variable Information _ Synapse.pdf, NTAP Adult PRO Variable Information_Synapse.pdf, ntapadult_finalforanalysis.sas7bdat, syn12617093asCSV.csv\n\n\n"}]}}